Table 2.
Type of Coronary Heart Disease (CHD) • represent a continuum of risk but also reflect varying pathology from chronic atherosclerotic and inflammatory processes to increased thrombotic and acute inflammatory perturbations |
•Stable CHD •Unstable Angina •NSTEMI •STEMI |
Coronary vs. peripheral arterial disease | •MI •Cerebrovascular atherosclerosis/ ischemic (non-embolic) stroke • Lower extremity peripheral arterial disease |
Atherosclerotic vs. non-atherosclerotic CVD | •Atherosclerotic CVD (ASCVD): • CHD, Cerebrovascular disease (atherosclerotic stroke, embolic stroke, hemorrhagic stroke), peripheral arterial disease •Non-atherosclerotic CVD: • Heart failure, arrhythmias, vascular stiffness, etc. |
Accounting for cardiometabolic medications | •Lipid-modifying drugs •Glucose-lowering drugs •Blood pressure drugs (affecting vascular tone) |
HDL=high density lipoprotein; CHD=coronary heart disease; NSTEMI=non-ST elevation myocardial infarction; STEMI=ST elevation myocardial infarction; MI=myocardial infarction; CVD=cardiovascular disease;